enzymes

German Biotech company BRAIN AG expands production capacities in Germany and Wales

Il BioeconomistaLeave a comment
Jürgen Eck, former CEO of BRAIN AG, Most Innovative Bioeconomy CEO 2018

The BRAIN Group announced an expansion of its production capacities. The installation of new production facilities in both Büttelborn, near Darmstadt, Germany, by WeissBioTech GmbH (WBT) and in Cardiff, Wales, by Biocatalysts Ltd. lays the foundation for future growth.

The companies of the BRAIN Group form a closely knit network in the fields of R&D and production or as suppliers in specific markets. Drawing on the particular competencies of its subsidiaries, BRAIN brings its own innovative research results to market launch and commercializes existing products. By expanding its production capacities, BRAIN reinforces the strategic focus on its product business.

Continue reading →

An exclusive interview with Alex Michine, CEO of MetGen. “Building consumer awareness is key for the expansion of the European bioeconomy”

Il Bioeconomista2 Comments
Alex Michine, CEO MetGen, with the Frost & Sullivan Award in London

MetGen is a Finnish company headquartered in Kaarina and founded in 2008 on the core competence of genetic engineering and synthetic biology.

In this exclusive interview with Il Bioeconomista, the CEO, Alex Michine, talks about the achievements and the next steps of the company and gives us his point of view regarding the bioeconomy in Finland and in the European Union.
Interview by Mario Bonaccorso

Continue reading →

Novozymes’ enzymes are available online through Alibaba’s platform

Il BioeconomistaLeave a comment
Source: Novozymes

Now, for the first time, Novozymes’ enzymes are available online through Alibaba’s platform for industrial products, 1688.com.

“We want to be a front runner in providing biological solutions online as well as offline. By partnering with Alibaba, we will get even closer to our end-customers, address local market needs faster and explore new application opportunities,” says Thomas Videbæk, COO and Executive Vice President, Novozymes.

Continue reading →

DSM continues to invest in the biofuel industry

Il BioeconomistaLeave a comment
Headquarter of Royal DSM in Heerlen (The Netherlands)

Royal DSM, a global science-based company active in health, nutrition and materials, headquartered in the Netherlands, will bring innovative solutions to the biofuels industry with a full portfolio offering of yeast and enzymes for starch, fiber and biomass conversions.

Continue reading →

Novozymes launched two new enzymes for the European ethanol market

Il BioeconomistaLeave a comment
Peder Hold Nielsen, CEO Novozymes

Novozymes launched two new enzymes for the European ethanol market. The two products (Spirizyme® 2.0 T and Spirizyme Ultra T) are part of the Spirizyme T Portfolio, an advanced suite of glucoamylase enzymes with trehalase that deliver yield enhancing activities documented to provide the highest total sugar conversion in the industry.

Continue reading →

Novozymes launches an enzyme that adds nearly $1 million per year in revenue for a plant

Il BioeconomistaLeave a comment
Novozymes Headquarter
Novozymes Headquarter

Novozymes launched the Spirizyme® T Portfolio, an advanced suite of glucoamylase enzymes with trehalase and other yield enhancing activities that provide the most total sugar conversion in the industry. Trehalase is an enzyme that converts trehalose, a type of sugar that cannot be fermented to ethanol, to glucose, which is easily fermentable.

Continue reading →

The future of Clariant is bio-based

Il BioeconomistaLeave a comment
image

Clariant new R&D center in Planegg, near Munich

Clariant’s cellulosic ethanol using sunliquid® technology can achieve price competitiveness with sugarcane ethanol pricing in Brazil. To say it is the Swiss chemical company in a note.

Continue reading →

Novozymes launches an enzyme that cuts chemical use at ethanol plants

Il BioeconomistaLeave a comment

image

Novozymes today announced the launch of Avantec® Amp, an advanced enzyme product that improves yield and throughput in corn ethanol production, while increasing corn oil extraction and significantly reducing the need for several harsh chemicals used in ethanol production. By switching from standard enzyme technology to Avantec Amp, a typical ethanol plant with a capacity of 110 million gallons can make up to $2.5 million a year in additional net profits.

Continue reading →

DuPont and Quad County Corn Processors Sign Enzyme Supply Contract for Cellulosic Biofuel

Il BioeconomistaLeave a comment

image

DuPont Industrial Biosciences and Quad County Corn Processors (QCCP) announced a new multi-year contract to supply the enzymes that enable QCCP’s Cellerate™ process in the production of cellulosic biofuel from corn kernel fiber.

Continue reading →

Novozymes will stick to its plans to develop transportation fuel made from agricultural waste

Il BioeconomistaLeave a comment
Novozymes Headquarter
Novozymes Headquarter

Denmark’s Novozymes , the world’s largest enzymes producer, will stick to its plans to develop transportation fuel made from agricultural waste, despite an oil price rout that has left oil-based products cheaper for consumers. Some analysts have expressed concern that a lower crude oil price might dampen investor interest in alternatives, but Novozymes said on Thursday that it aims to provide enzymes to 15 advanced bioethanol plants by 2017, up from five, generating 1 billion Danish crowns ($165.7 million) in revenue.

 

Continue reading →